Selected research
Industry Research
Human Digital Pathology Industry Research Report 2026
Market perspective
The global Human Digital Pathology market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Human Digital Pathology market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Human Digital Pathology market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Human Digital Pathology market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Human Digital Pathology include Danaher Corporation, Fujifilm, Philips Healthcare, Mikroscan, 3DHISTECH, PathAI, Roche, Hamamatsu Photonics and Apollo Enterprise Imaging, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Human Digital Pathology market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Human Digital Pathology.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Human Digital Pathology Market by Company
Danaher Corporation
Fujifilm
Philips Healthcare
Mikroscan
3DHISTECH
PathAI
Roche
Hamamatsu Photonics
Apollo Enterprise Imaging
XIFIN
KFBIO
Aiforia
Glencoe Software
Human Digital Pathology Segment by Type
Scanner
Software
Human Digital Pathology Segment by Application
Hospitals
Scientific Research
Human Digital Pathology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Digital Pathology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Digital Pathology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Digital Pathology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Human Digital Pathology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Scanner
- Software
Applications
- Hospitals
- Scientific Research
Companies covered
- Danaher Corporation
- Fujifilm
- Philips Healthcare
- Mikroscan
- 3DHISTECH
- PathAI
- Roche
- Hamamatsu Photonics
- Apollo Enterprise Imaging
- XIFIN
- KFBIO
- Aiforia
- Glencoe Software
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Human Digital Pathology by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Scanner
- 2.2.3 Software
- 2.3 Human Digital Pathology by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Scientific Research
- 2.4 Assumptions and Limitations
3 Human Digital Pathology Breakdown Data by Type
- 3.1 Global Human Digital Pathology Historic Market Size by Type (2021-2026)
- 3.2 Global Human Digital Pathology Forecasted Market Size by Type (2027-2032)
4 Human Digital Pathology Breakdown Data by Application
- 4.1 Global Human Digital Pathology Historic Market Size by Application (2021-2026)
- 4.2 Global Human Digital Pathology Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Human Digital Pathology Market Perspective (2021-2032)
- 5.2 Global Human Digital Pathology Growth Trends by Region
- 5.2.1 Global Human Digital Pathology Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Human Digital Pathology Historic Market Size by Region (2021-2026)
- 5.2.3 Human Digital Pathology Forecasted Market Size by Region (2027-2032)
- 5.3 Human Digital Pathology Market Dynamics
- 5.3.1 Human Digital Pathology Industry Trends
- 5.3.2 Human Digital Pathology Market Drivers
- 5.3.3 Human Digital Pathology Market Challenges
- 5.3.4 Human Digital Pathology Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Human Digital Pathology Players by Revenue
- 6.1.1 Global Top Human Digital Pathology Players by Revenue (2021-2026)
- 6.1.2 Global Human Digital Pathology Revenue Market Share by Players (2021-2026)
- 6.2 Global Human Digital Pathology Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Human Digital Pathology Head Office and Area Served
- 6.4 Global Human Digital Pathology Players, Product Type & Application
- 6.5 Global Human Digital Pathology Manufacturers Established Date
- 6.6 Global Human Digital Pathology Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Human Digital Pathology Market Size (2021-2032)
- 7.2 North America Human Digital Pathology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Human Digital Pathology Market Size by Country (2021-2026)
- 7.4 North America Human Digital Pathology Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Human Digital Pathology Market Size (2021-2032)
- 8.2 Europe Human Digital Pathology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Human Digital Pathology Market Size by Country (2021-2026)
- 8.4 Europe Human Digital Pathology Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Human Digital Pathology Market Size (2021-2032)
- 9.2 Asia-Pacific Human Digital Pathology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Human Digital Pathology Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Human Digital Pathology Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Human Digital Pathology Market Size (2021-2032)
- 10.2 South America Human Digital Pathology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Human Digital Pathology Market Size by Country (2021-2026)
- 10.4 South America Human Digital Pathology Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Human Digital Pathology Market Size (2021-2032)
- 11.2 Middle East & Africa Human Digital Pathology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Human Digital Pathology Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Human Digital Pathology Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Danaher Corporation
- 12.1.1 Danaher Corporation Company Information
- 12.1.2 Danaher Corporation Business Overview
- 12.1.3 Danaher Corporation Revenue in Human Digital Pathology Business (2021-2026)
- 12.1.4 Danaher Corporation Human Digital Pathology Product Portfolio
- 12.1.5 Danaher Corporation Recent Developments
- 12.2 Fujifilm
- 12.2.1 Fujifilm Company Information
- 12.2.2 Fujifilm Business Overview
- 12.2.3 Fujifilm Revenue in Human Digital Pathology Business (2021-2026)
- 12.2.4 Fujifilm Human Digital Pathology Product Portfolio
- 12.2.5 Fujifilm Recent Developments
- 12.3 Philips Healthcare
- 12.3.1 Philips Healthcare Company Information
- 12.3.2 Philips Healthcare Business Overview
- 12.3.3 Philips Healthcare Revenue in Human Digital Pathology Business (2021-2026)
- 12.3.4 Philips Healthcare Human Digital Pathology Product Portfolio
- 12.3.5 Philips Healthcare Recent Developments
- 12.4 Mikroscan
- 12.4.1 Mikroscan Company Information
- 12.4.2 Mikroscan Business Overview
- 12.4.3 Mikroscan Revenue in Human Digital Pathology Business (2021-2026)
- 12.4.4 Mikroscan Human Digital Pathology Product Portfolio
- 12.4.5 Mikroscan Recent Developments
- 12.5 3DHISTECH
- 12.5.1 3DHISTECH Company Information
- 12.5.2 3DHISTECH Business Overview
- 12.5.3 3DHISTECH Revenue in Human Digital Pathology Business (2021-2026)
- 12.5.4 3DHISTECH Human Digital Pathology Product Portfolio
- 12.5.5 3DHISTECH Recent Developments
- 12.6 PathAI
- 12.6.1 PathAI Company Information
- 12.6.2 PathAI Business Overview
- 12.6.3 PathAI Revenue in Human Digital Pathology Business (2021-2026)
- 12.6.4 PathAI Human Digital Pathology Product Portfolio
- 12.6.5 PathAI Recent Developments
- 12.7 Roche
- 12.7.1 Roche Company Information
- 12.7.2 Roche Business Overview
- 12.7.3 Roche Revenue in Human Digital Pathology Business (2021-2026)
- 12.7.4 Roche Human Digital Pathology Product Portfolio
- 12.7.5 Roche Recent Developments
- 12.8 Hamamatsu Photonics
- 12.8.1 Hamamatsu Photonics Company Information
- 12.8.2 Hamamatsu Photonics Business Overview
- 12.8.3 Hamamatsu Photonics Revenue in Human Digital Pathology Business (2021-2026)
- 12.8.4 Hamamatsu Photonics Human Digital Pathology Product Portfolio
- 12.8.5 Hamamatsu Photonics Recent Developments
- 12.9 Apollo Enterprise Imaging
- 12.9.1 Apollo Enterprise Imaging Company Information
- 12.9.2 Apollo Enterprise Imaging Business Overview
- 12.9.3 Apollo Enterprise Imaging Revenue in Human Digital Pathology Business (2021-2026)
- 12.9.4 Apollo Enterprise Imaging Human Digital Pathology Product Portfolio
- 12.9.5 Apollo Enterprise Imaging Recent Developments
- 12.10 XIFIN
- 12.10.1 XIFIN Company Information
- 12.10.2 XIFIN Business Overview
- 12.10.3 XIFIN Revenue in Human Digital Pathology Business (2021-2026)
- 12.10.4 XIFIN Human Digital Pathology Product Portfolio
- 12.10.5 XIFIN Recent Developments
- 12.11 KFBIO
- 12.11.1 KFBIO Company Information
- 12.11.2 KFBIO Business Overview
- 12.11.3 KFBIO Revenue in Human Digital Pathology Business (2021-2026)
- 12.11.4 KFBIO Human Digital Pathology Product Portfolio
- 12.11.5 KFBIO Recent Developments
- 12.12 Aiforia
- 12.12.1 Aiforia Company Information
- 12.12.2 Aiforia Business Overview
- 12.12.3 Aiforia Revenue in Human Digital Pathology Business (2021-2026)
- 12.12.4 Aiforia Human Digital Pathology Product Portfolio
- 12.12.5 Aiforia Recent Developments
- 12.13 Glencoe Software
- 12.13.1 Glencoe Software Company Information
- 12.13.2 Glencoe Software Business Overview
- 12.13.3 Glencoe Software Revenue in Human Digital Pathology Business (2021-2026)
- 12.13.4 Glencoe Software Human Digital Pathology Product Portfolio
- 12.13.5 Glencoe Software Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst